Alpine Associates Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Alpine Associates Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,309,111	Closed	-$56.6M	–	70
2015 Q3	$56.6M	Buy	+1,309,111	New	+$55.2M	2.21%	16

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Alpine Associates Management's WX Position: Q4 2015 in Review

Alpine Associates Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,309,111 shares — an estimated $56.6M sold.

Alpine Associates Management first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $56.6M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Alpine Associates Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Alpine Associates Management sold 1,309,111 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $56.6M.
Alpine Associates Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
Alpine Associates Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $56.6M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Alpine Associates Management's 13F filing for Q4 2015, filed 11 Feb 2016.